NanoString Technologies, Inc. and Fluidigm Corporation Settle Lawsuits
4:30p ET October 1, 2013 (GlobeNewswire)
NanoString Technologies, Inc. (Nasdaq:NSTG) and Fluidigm Corporation (Nasdaq:FLDM) have agreed to settle lawsuits filed by Fluidigm in the United States and Singapore. In the U.S. case, Fluidigm charged NanoString with false advertising, unfair competition, and unlawful trade practices based on a comparison study of NanoString's Single Cell Gene Expression Assay on the nCounter Analysis System with the Single Cell Gene Expression capabilities of Fluidigm's BioMark(TM) HD system. The lawsuit in Singapore was based on the same study and contained similar allegations. NanoString denies the allegations in both lawsuit
HOW WILL THIS AFFECT PRICE TOMORROW?
